Pituitary hormones as neurotrophic signals: Update on hypothalamic differentiation in genetic models of altered feedback

Proceedings of the Society for Experimental Biology and Medicine

Volumn 222, Issue 1, 1999, Pages 39-58

  Phelps, Carol J ^a   Hurley, David L ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS HORMONE; MESSENGER RNA; NEUROTROPHIC FACTOR; PROLACTIN; SOMATOSTATIN;

DOPAMINERGIC NERVE CELL; FEEDBACK SYSTEM; GENE EXPRESSION; GENE MUTATION; GENETIC MODEL; HORMONE ACTION; HYPOTHALAMUS; NERVE CELL DIFFERENTIATION; NEUROTROPISM; NONHUMAN; SHORT SURVEY;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0032881808     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1373.1999.09994.x     Document Type: Short Survey

References (196)

1. Phelps CJ. Pituitary hormones as neurotrophic signals: Anomalous hypophysiotropic neuron differentiation in hypopituitary dwarf mice. Proc Soc Exp Biol Med 206:6-23, 1994.
2. Hurley DL, Wee BE, Phelps CJ. Hypophysiotropic somatostatin expression during postnatal development in growth hormone-deficient. Ames dwarf mice: mRNA in situ hybridization. Neuroendocrinology 65:98-106, 1997.
3. Phelps CJ, Dalcik H, Endo H, Talamantes F, Hurley DL. Growth hormone-releasing hormone peptide and mRNA are overexpressed in GH-deficient Ames dwarf mice. Endocrinology 133:3034-3037, 1993.
4. Hurley DL, Wee BE, Phelps CJ. Growth hormone-releasing hormone expression during postnatal development in growth hormone-deficient Ames dwarf mice: mRNA in situ hybridization. Neuroendocrinology 68:201-209, 1998.
5. Morgan WW, Bartke A, Pfiel K. Deficiency of dopamine in the median eminence of Snell dwarf mice. Endocrinology 109:2069-2075, 1981.
6. Phelps CJ, Sladek JR Jr, Morgan WW, Bartke A. Hypothalamic catecholamine histofluorescence in dwarf mice. Cell Tissue Res 240:19-25, 1985.
7. Phelps CJ, Carlson SW, Vaccarella MY, Felten SY. Developmental assessment of hypothalamic tuberoinfundibular dopamine in prolactin-deficient dwarf mice. Endocrinology 132:2715-2722, 1993.
8. Phelps CJ, Saleh MN, Romero MI. Hypophysiotropic somatostatin expression during postnatal development in growth hormone-deficient Ames dwarf mice: Peptide immunocytochemistry. Neuroendocrinology 64:364-378, 1996.
9. Morgan WW, Besch KC. Effect of prolactin replacement on the number of tyrosine hydroxylase neurons in the arcuate nuclei of Ames dwarf and normal mice. Neuroendocrinology 52:70-74, 1990.
10. Phelps CJ, Carlson SW, Vaccarella MY. Hypothalamic dopaminergic neurons in prolactin-deficient Ames dwarf mice: Localization and quantification of deficit by tyrosine hydroxylase immunocytochemistry. J Neuroendocrinol 6:145-152, 1994.
11. O'Hara BF, Bendotti C, Reeves RH, Oster-Granite ML, Gearhart JD. Genetic mapping and analysis of somatostatin expression in Snell dwarf mice. Mol Brain Res 4:283-292, 1988.
12. Fuhrmann G, Scala-Guenot DD, Ebel A. Somatostatin levels in the central nervous system of the Snell dwarf mouse: Is somatostatin excess the primary molecular defect in the dw/dw dwarfism? Brain Res 328:161-164, 1985.
13. Webb SM, Lewinski AK, Steger RW, Reiter RJ, Bartke A. Deficiency of immunoreactive somatostatin in the median eminence of Snell dwarf mice. Life Sci 36:1239-1245, 1985.
14. Phelps CJ, Hoffman GE. Isolated deficiency of immunocytochemically detected somatostatin in Snell dwarf, but not in "Little" mice. Peptides 8:1127-1133, 1987.
15. Phelps CJ. Isolated deficiency of tyrosine hydroxylase immunoreactivity in tuberoinfundibular neurons in pituitary prolactin-deficient Snell dwarf mice. Brain Res 416:354-358, 1987.
16. Phelps CJ, Romero MA, Malcamp C, Joseph SR. TIDA neuron number in developing Snell dwarf mice (abstract). Soc Neurosci Abst 459.11, 1997.
17. Frohman MA, Downs TR, Chomczynski P, Frohman LA. Cloning and characterization of mouse growth hormone-releasing hormone (GRH) complementary DNA: Increased GRH messenger RNA levels in the growth hormone-deficient lit/lit mouse. Mol Endocrinol 3:1529-1536, 1989.
18. Pellegrini E, Carmignac DF, Bluet-Pajot MT, Mounier F, Bennett P, Epelbaum J, Robinson IC. Intrahypothalamic growth hormone feedback: From dwarfism to acromegaly in the rat. Endocrinology 138:4543-1551, 1997.
19. Thomas GB, Phelps CJ, Robinson IC. Differential regulation in hypothalamic tuberoinfundibular dopamine neurons in two dwarf rat models with contrasting changes in pituitary prolactin. J Neuroendocrinol 11:229-236, 1999.
20. Sakuma S, Ishikawa H, Okuma S. The cell population of somatostatin and growth hormone-releasing factor using quantitative immunohistochemistry in the isolated GH-deficient dwarf rat. Brain Res 506:307-310, 1990.
21. Hurley DL, Phelps CJ. Hypothalamic pre-prosomatostatin mRNA expression in mice transgenic for excess or deficient endogenous growth hormone. Endocrinology 130:1809-1815, 1992.
22. Hurley DL, Phelps CJ. Altered hypothalamic growth hormone releasing hormone mRNA expression in mice transgenic for excess or deficient endogenous growth hormone. Mol Cell Neurosci 4:237-244, 1993.
23. Phelps CJ, Carlson SW, Hurley DL. Hypothalamic dopaminergic neurons in transgenic dwarf mice: Histofluorescence, immunocytochemical, and in situ hybridization studies. Anat Rec 231:445-456, 1991.
24. Hurley DL, Bartke A, Wagner TE, Wee BE, Phelps CJ. Increased hypothalamic somatostatin expression in mice transgenic for bovine or human GH. J Neuroendocrinol 6:539-548, 1994.
25. Phelps CJ, Bartke A. Stimulatory effect of human, but not bovine, growth hormone expression on numbers of tuberoinfundibular dopaminergic neurons in transgenic mice. Endocrinology 138:2849-2855, 1997.
26. Flavell DM, Wells T, Wells SE, Carmignac DF, Thomas GB, Robinson ICAF. Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons. EMBO J 15:3871-3879, 1996.
27. Merchenthaler I, Setalo G, Csontos C, Petrusz P, Flerko B, Negro-Vilar A. Combined retrograde tracing and immunocytochemical identification of luteinizing hormone-releasing hormone- and somatostatin-containing neurons projecting to the median eminence of the rat. Endocrinology 125:2812-2821, 1989.
28. Niimi M, Takahara J, Sato M, Kawanishi K. Identification of DA-and GHRF-containing neurons projecting to the median eminence of the rat by combined retrograde tracing and immunohistochemistry. Neuroendocrinology 55:92-96, 1992.
29. Tannenbaum GS, Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115:1952-1957, 1984.
30. Plotsky PM, Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 230:461-463, 1985.
31. Maiter DM, Gabriel SM, Koenig JI, Russell WE, Martin JB. Sexual differentiation of growth hormone feedback effects on hypothalamic growth hormone-releasing hormone and somatostatin. Neuroendocrinology 51:174-180, 1990.
32. Chomczynski P, Downs TR, Frohman LA. Feedback regulation of growth hormone (GH)-releasing hormone gene expression by GH in rat hypothalamus. Mol Endocrinol 2:236-241, 1988.
33. de Gennaro Colonna V, Cattaneo E, Cocchi D, Müller EE, Maggi A. Growth hormone regulation of growth-releasing hormone gene expression. Peptides 9:985-988, 1988.
34. MacLeod RM. Regulation of PRL secretion. In: Martini L, Ganong WF, Eds. Frontiers in Neuroendocrinology, Vol. 4. New York: Raven Press, pp169-194, 1976.
35. Ben-Jonathan N. Dopamine: A prolactin-inhibitory hormone. Endocr Rev 6:564-589, 1985.
36. Arbogast LA, Voogt JL. Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta. Endocrinology 128:997-1005, 1991.
37. Snell GD. Dwarf, a new Mendelian recessive character of the house mouse. Proc Natl Acad Sci U S A 15:733-734, 1929.
38. Eicher EM, Beamer WG. New mouse dw allele: Genetic location and effects on lifespan and growth hormone levels. J Hered 71:187-190, 1980.
39. Schaible R, Gowen JW. A new dwarf mouse. Genetics 46:896, 1961.
40. Slabaugh MB, Lieberman ME, Rutledge JJ, Gorski J. Growth hormone and prolactin synthesis in normal and homozygous Snell and Ames dwarf mice. Endocrinology 109:1040-1046, 1981.
41. Eicher EM, Beamer WG. Inherited ateliotic dwarfism in mice. J Hered 67:87-91, 1976.
42. Cheng TC, Beamer WG, Phillips JA III, Bartke A, Mallonee RL, Dowling C. Etiology of growth hormone deficiency in little, Ames, and Snell dwarf mice. Endocrinology 113:1669-1678, 1983.
43. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232, 1993.
44. Lin S-C, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364:208-213, 1993.
45. Charlton HM, Clark RG, Robinson IC, Goff AE, Cox BS, Bugnon C, Bloch BA. Growth hormone-deficient dwarfism in the rat: A new mutation. J Endocrinol 119:51-58, 1988.
46. Okuma S, Kawashima S. Spontaneous dwarf rat. Exp Anim 29:301-304, 1980.
47. Nogami H, Takeuchi T, Suzuki K, Okuma S, Ishikawa H. Studies on prolactin and growth hormone gene expression in the pituitary gland of spontaneous dwarf rats. Endocrinology 125:964-970, 1989.
48. Takeuchi T, Suzuki H, Sakurai S, Nogami H, Okuma S, Ishikawa H. Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: Detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction. Endocrinology 126:31-38, 1990.
49. Behringer RR, Mathews LS, Palmiter RD, Brinster RL. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453-461, 1988.
50. Borrelli E, Heyman RA, Arias C, Sawchenko PE, Evans RM. Transgenic mice with inducible dwarfism. Nature 339:538-541, 1989.
51. Struthers RS, Vale WW, Arias C, Sawchenko PE, Montminy MR. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a nonphosphorylatable CREB mutant. Nature 350:622-624, 1991.
52. Hammer RE, Brinster RL, Rosenfeld MG, Evans RNI, Mayo KE. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413-417, 1985.
53. Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606-612, 1988.
54. Steger RW, Bartke A, Parkening TA, Collins T, Buonomo F, Tang K, Wagner TE, Yun JS. Effects of heterologous growth hormones on hypothalamic and pituitary function in transgenic mice. Neuroendocrinology 53:365-372, 1991.
55. Bartke A, Cecim M, Tang K, Steger R, Chandrashekar V, Turyn D. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice. Proc Soc Exp Biol Med 206:345-359, 1994.
56. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257:1115-1118, 1992.
57. Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van der Brande JL, Rosenfeld MG, Ingraham HA. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257:1118-1121, 1992.
58. Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, Inagaki H, Endo F, Matsuda I. Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 189:851-855, 1992.
59. Parks JS, Pfäffle RW, Brown MR, Abdul-Latif H, Meacham LR. Growth hormone deficiency. In: Weintraub BD, Ed. Molecular Endocrinology: Basic Concepts and Clinical Correlations. New York: Raven Press, Ltd., pp473-190, 1995.
60. Wajnrajch MP, Gertner JM, Harbison MD, Chua SC Jr, Leibel RL. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 12:88-90, 1996.
61. Baumann G, Maheshwari H. The dwarfs of Sindh: Severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. Acta Paediatr Suppl 423:33-38, 1997.
62. Brown MR, Parks JS, Adess ME, Rich BH, Rosenthal IM, Voss TC, VanderHeyden TC, Hurley DL. Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Horm Res 49:98-102, 1998.
63. Li S, Crenshaw EB III, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 347:528-533, 1990.
64. Rhodes SJ, Dimattia GE, Rosenfeld MG. Transcriptional mechanisms in anterior pituitary cell differentiation. Curr Opin Genet Dev 4:709-717, 1994.
65. Theill LE, Karin M. Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 14:670-689, 1993.
66. Bartke A. Chromosomal location of the df mutation. Mouse Newsletter 32:52-53, 1965.
67. Buckwalter MS, Katz R, Camper SA. Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 10:515-526, 1991.
68. Andersen B, Pearse RV II, Jenne K, Somson M, Lin S-C, Bartke A, Rosenfeld MG. The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol 172:495-503, 1995.
69. Gage PJ, Lossie AC, Scarlett LM, Lloyd RV, Camper SA. Ames dwarf mice exhibit somatotrope commitment but lack growth hormone-releasing factor response. Endocrinology 136:1161-1167, 1995.
70. Somson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carrière C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327-333, 1996.
71. Treier M, Rosenfeld MG. The hypothalamic-pituitary axis: Codevelopment of two organs. Curr Opin Cell Biol 8:833-843, 1996.
72. Wu W, Cogan JD, Pfäffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JA III, Rosenfeld MG. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18:147-149, 1998.
73. Mouse Genome Informatics Resource. [On-line]. Available: http:// www.informatics.jax.org. Mouse Genome Informatics. Bar Harbor, Maine: The Jackson Laboratory, 1998.
74. Hermesz E, Mackem S, Mahon KA. Rpx: A novel anterior restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 122:41-52, 1996.
75. Thomas PQ, Johnson BV, Rathjen J, Rathjen PD. Sequence, genomic organization, and expression of the novel homeobox gene Hesx1. J Biol Chem 270:3869-3875, 1995.
76. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 10:1570-1581, 1996.
77. Dattani MT, Martinez-Barbera IP, Thomas PQ, Brickman JM, Gupta R, Mårtensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19:125-133, 1998.
78. Sheng HZ, Zhadanov AB, Mosinger B Jr, Fujii T, Bertuzzi S, Grinberg A, Lee EJ, Huang S-P, Mahon KA, Westphal H. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 272:1004-1007, 1996.
79. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA, Westphal H. Multistep control of pituitary organogenesis. Science 278:1809-1812, 1997.
80. Bach I, Rhodes SJ, Pearse RV II, Heinzel T, Gloss B, Scully KM, Sawchenko PE, Rosenfeld MG. P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci U S A 92:2720-2724, 1995.
81. Seidah NG, Barale J, Marcinkiewicz M, Mattei M, Day R, Chretien M. The mouse homeoprotein mLIM-3 is expressed early in cells derived from the neuroepithelium and persists in adult pituitary. DNA 13:1163-1180, 1994.
82. Sasaki F, Sano M. Role of the ovary in the sexual differentiation of prolactin and growth hormone cells in the mouse adenohypophysis: Stereological morphometric study by electron microscopy. J Endocrinol 9:117-121, 1982.
83. Gage PJ, Roller ML, Saunders TL, Scarlett LM, Camper SA. Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. Development 122:151-160, 1996.
84. Wilson DB, Wyatt DP. Immunocytochemistry of TSH cells during development of the dwarf mutant mouse. Anat Embryol (Berl) 174:277-282, 1986.
85. Wilson DB, Wyatt DP. Immunocytochemistry of ambiguous cells in adult and embryonic dwarf (dw) mouse pituitaries. Anat Rec 236:671-678, 1993.
86. Wilson DB, Wyatt DP. Ultrastructural immunocytochemistry of somatotrophs and mammotrophs in embryos of the dwarf mutant mouse. Anat Rec 215:282-287, 1986.
87. Slabaugh MB, Lieberman ME, Rutledge JJ, Gorski J. Ontogeny of growth hormone and prolactin gene expression in mice. Endocrinology 110:1489-1497, 1982.
88. Hurley DL, Wojtkiewicz PW, Phelps CJ. Growth hormone and Pit-1 mRNA detection by reverse transcription: Polymerase chain reaction in adult and developing Ames dwarf mice. Rec Prog Horm Res 50:443-448, 1995.
89. Grumbach IM, Veh RW. The SA/rABC technique: A new ABC procedure for detection of antigens at increased sensitivity. J Histochem Cytochem 43:31-37, 1995.
90. Phelps CJ, Vaccarella MY, Romero MI, Hurley DL. Postnatal reduction in number of hypothalamic tuberoinfundibular dopaminergic neurons in prolactin-deficient dwarf mice. Neuroendocrinology 59:189-196, 1994.
91. Romero MI, Phelps CJ. Prolactin replacement during development prevents dopaminergic deficit in hypothalamic arcuate nucleus of prolactin-deficient Ames dwarf mice. Endocrinology 133:1860-1870, 1993.
92. Romero MI, Phelps CJ. Prolactin replacement in adult dwarf mice does not reverse the deficit in tuberoinfundibular dopaminergic neuron number. Endocrinology 136:3238-3246, 1995.
93. Palmiter RD, Norstedt G, Gelinas RE, Hammer RE, Brinster RL. Metallothionein-human GH fusion genes stimulate growth of mice. Science 222:809-814, 1983.
94. McGrane MM, de Vente J, Yun J, Bloom J, Park E, Wynshaw-Boris A, Wagner T, Rottman FM, Hanson RW. Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/growth hormone gene in transgenic mice. J Biol Chem 263:11443-11451, 1988.
95. Milton S, Cecim M, Li YS, Yun JS, Wagner TE, Bartke A. Transgenic female mice with high human growth hormone levels are fertile and capable of normal lactation without having been pregnant. Endocrinology 131:536-538, 1992.
96. Chandrashekar V, Bartke A, Wagner TE. Neuroendocrine function in adult female transgenic mice expressing the human growth hormone gene. Endocrinology 130:1802-1808, 1992.
97. Meister B, Hökfelt T, Vale WW, Sawchenko PE, Swanson L, Goldstein M. Coexistence of tyrosine hydroxylase and growth hormone-releasing factor in a subpopulation of tuberoinfundibular neurons of the rat. Neuroendocrinology 42:237-247, 1986.
98. Furness JB, Heath JW, Costa M. Aqueous aldehyde (Faglu) methods for the fluorescence histochemical localization of catecholamines for ultrastructural studies of central nervous tissue. Histochemistry 57:289-295, 1978.
99. Sato M, Frohman LA. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology 133:793-799, 1993.
100. Kelly PA, Djiane J, Postel-Vinay M-C, Edery M. The prolactin/ growth hormone receptor family. Endocr Rev 12:235-251, 1991.
101. Kelly PA, Djiane J, Edery M. Different forms of the prolactin receptor: Insights into the mechanism of prolactin action. Trends Endocrinol Metab 3:54-59, 1992.
102. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: Actions, signal transduction pathways, and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268, 1998.
103. Burton KA, Kabigting EB, Clifton DK, Steiner RA. Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. Endocrinology 131:958-963, 1992.
104. Burton KA, Kabigting EB, Steiner RA, Clifton DK. Identification of target cells for growth hormone's action in the arcuate nucleus. Am J Physiol 269:E716-E722, 1995.
105. Chan YY, Steiner RA, Clifton DK. Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology 137:1319-1325, 1996.
106. Kamegai J, Minami S, Sugihara H, Hasegawa O, Higuchi H, Wakabayashi I. Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. Endocrinology 137:2109-2112, 1996.
107. McDonald JK, Lumpkin MD, Samson WK, McCann SM. Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci U S A 82:561-564, 1985.
108. Bennett PA, Levy A, Sophokleous S, Robinson IC, Lightman SL. Hypothalamic GH receptor gene expression in the rat: Effects of altered GH status. J Endocrinol 147:225-234, 1995.
109. Chiu S, Koos RD, Wise PM. Detection of prolactin receptor (PRL-R) mRNA in the rat hypothalamus and pituitary gland. Endocrinology 130:1747-1749, 1992.
110. Chiu S, Wise PM. Prolactin receptor mRNA localization in the hypothalamus by in situ hybridization. J Neuroendocrinol 6:191-199, 1994.
111. Crumeyrolle-Arias M, Latouche J, Jammes H, Djiane J, Kelly PA, Reymond MJ, Haour F. Prolactin receptors in the rat hypothalamus: Autoradiographic localization and characterization. Neuroendocrinology 57:457-466, 1993.
112. Roky R, Paut-Pagano L, Coffin V, Kitahama K, Valatx J-L, Kelly PA, Jouvet M. Distribution of prolactin receptors in the rat forebrain. Neuroendocrinology 63:422-429, 1996.
113. Bakowska JC, Morrell JI. Atlas of the neurons that express mRNA for the long form of the prolactin receptor in the forebrain of the female rat. J Comp Neurol 386:161-177, 1997.
114. Pi X-J, Grattan DR. Differential expression of the two forms of prolactin receptor mRNA within microdissected hypothalamic nuclei of the rat. Mol Brain Res 59:1-12, 1998.
115. Arbogast LA, Voogt JL. Prolactin (PRL) receptors are colocalized in dopaminergic neurons in fetal hypothalamic cell cultures: Effect of PRL on tyrosine hydroxylase activity. Endocrinology 138:3016-3023, 1997.
116. Lerant A, Freeman ME. Ovarian steroids differentially regulate the expression of PRL-R in neuroendocrine dopaminergic neuron populations: A double label confocal microscopic study. Brain Res 802:141-152, 1998.
117. Minami S, Kamegai J, Sugihara H, Hasegawa O, Wakabayashi I. Systemic administration of recombinant human growth hormone in-duces expression of the c-fos gene in the hypothalamic arcuate and periventricular nuclei in hypophysectomized rats. Endocrinology 131:247-253, 1992.
118. Kamegai J, Minami S, Sugihara H, Higuchi H, Wakabayashi I. Growth hormone induces expression of the c-fos gene in hypothalamic neuropeptide-Y and somatostatin neurons in hypophysectomized rats. Endocrinology 135:2765-2771, 1994.
119. Chan YY, Clifton DK, Steiner RA. Role of NPY neurones in GH-dependent feedback signalling to the brain. Horm Res 45(Suppl 1): 12-14, 1996.
120. Bennett PA, Thomas GB, Howard AD, Feighner SD, van der Ploeg LH, Smith RG, Robinson IC. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 138:4552-4557, 1997.
121. Suzuki N, Okada K, Minami S, Wakabayashi I. Inhibitory effect of neuropeptide Y on growth hormone secretion in rats is mediated by both Yl- and Y2-receptor subtypes and abolished after anterolateral deafferentiation of the medial basal hypothalamus. Regul Pept 65:145-151, 1996.
122. Dumont Y, Fournier A, St-Pierre S, Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in rat brain. J Neurosci 13:73-86, 1993.
123. Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur J Neurosci 5:1622-1637, 1993.
124. Hisano S, Tsuruo Y, Katogani Y, Daikoku S, Chihara K. Immunohistochemical evidence for synaptic connections between neuropeptide Y-containing axons and periventricular somatostatin neurons in the anterior hypothalamus in rats. Brain Res 520:170-177, 1990.
125. Rettori V, Milenkovic L, Aguila MC, McCann SM. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 126:2296-2301, 1990.
126. Aguilar RC, Fernandez HN, Dellacha JM, Calandra RS, Bartke A, Ghosh PK, Turyn D. Somatotropic and lactotropic receptors in transgenic mice expressing human or bovine growth hormone genes. Transgenic Res 1:221-227, 1992.
127. Ciofi P, Fallon JH, Croix D, Polack JM, Tramu G. Expression of neuropeptide Y precursor-immunoreactivity in the hypothalamic dopaminergic tubero-infundibular system during lactation in rodents. Endocrinology 128:823-834, 1991.
128. Malabu UH, Kilpatrick A, Ware M, Vernon RG, Williams G. Increased neuropeptide Y concentrations in specific hypothalamic regions of lactating rats: Possible relationship to hyperphagia and adaptive changes in energy balance. Peptides 15:83-87, 1994.
129. Smith MS. Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology 133:1258-1265, 1993.
130. Pape J-R, Tramu G. Suckling-induced changes in neuropeptide Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat: Evaluation of a putative intervention of prolactin. Neuroendocrinology 63:540-549, 1996.
131. Li C, Chen P, Smith MS. The acute suckling stimulus induces expression of neuropeptide Y (NPY) in cells in the dorsomedial hypothalamus and increases NPY expression in the arcuate nucleus. Endocrinology 139:1645-1652, 1998.
132. Ghosh PK, Debeljuk L, Wagner TE, Bartke A. Effect of immunoneutralization of neuropeptide Y on gonadotropin and prolactin secretion in normal mice and in transgenic mice bearing bovine growth hormone gene. Endocrinology 129:597-602, 1991.
133. Hyde JF, Bartke A, Davis BM. Galanin gene expression in the hypothalamopituitary axis of the Ames dwarf mouse. Mol Cell Neurosci 4:298-303, 1993.
134. Chan YY, Grafstein-Dunn E, Delemarre-van de Waal HA, Burton KA, Clifton DK, Steiner RA. The role of galanin and its receptor in the feedback regulation of growth hormone secretion. Endocrinology 137:5303-5310, 1996.
135. Wynick D, Small CJ, Bacon A, Holmes FE, Norman M, Ormandy CJ, Kilic E, Kerr NC, Ghatei M, Talamantes F, Bloom SR, Pachnis V. Galanin regulates prolactin release and lactotroph proliferation. Proc Natl Acad Sci U S A 95:12671-12676, 1998.
136. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977, 1996.
137. Pong S-S, Chaung L-HP, Dean DC, Nargund RP, Patchett AA, Smith RG. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 10:57-61, 1996.
138. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114:1537-1545, 1984.
139. Dickson SL, Doutrelant-Viltart O, Leng G. GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J Endocrinol 146:519-526, 1995.
140. Sara VR, Uvnas-Moberg K, Uvnas B, Hall K, Wetterberg L, Posloncec B, Goiny M. The distribution of somatomedins in the nervous system of the cat and their release following neural stimulation. Acta Physiol Scand 115:467-470, 1982.
141. Adem A, Jossan SS, d'Argy R, Gillberg PG, Nordberg A, Winblad B, Sara V. Insulin-like growth factor I (IGF-I) receptors in the human brain: Quantitative autoradiographic localization. Brain Res 503:299-303, 1989.
142. Araujo DM, Lapchak PA, Collier B, Chabot J-G. Quirion R. Insulin-like growth factor I (somatomedin-C) receptors in the rat brain: Distribution and interaction with the hippocampal cholinergic system. Brain Res 484:130-138, 1989.
143. Ocrant I, Valentino KL, Eng LF, Hintz RL, Wilson DM, Rosenfeld RG. Structural and immunohistochemical characterization of insulin-like growth factor I and II receptors in the murine central nervous system. Endocrinology 123:1023-1034, 1988.
144. Nissley SP, Knazek RA, Wolff GL. Somatomedin activity in sera of genetically small mice. Horm Metab Res 12:158-164, 1980.
145. Noguchi T, Kurata LM, Sugisaki T. Presence of a somatomedin-C-immunoreactive substance in the central nervous system: Immunohistochemical mapping studies. Neuroendocrinology 46:277-282, 1987.
146. Minami S, Suzuki N, Sugihara H, Tamura H, Emoto N, Wakabayashi I. Microinjection of rat GH but not human IGF-1 into a defined area of the hypothalamus inhibits endogenous GH secretion in rats. J Endocrinol 153:283-290, 1997.
147. McCarthy GF, Beaudet A, Tannenbaum GS. Colocalization of somatostatin receptors and growth hormone-releasing factor immunoreactivity in neurons of the rat arcuate nucleus. Neuroendocrinology 56:18-24, 1992.
148. Bertherat J, Doumaud P, Bérod A, Normand E, Bloch B, Rosténe W, Kordon C, Epelbaum J. Growth hormone-releasing hormone-synthesizing neurons are a subpopulation of somatostatin receptor-labelled cells in the rat arcuate nucleus: A combined in situ hybridization and receptor light-microscopic radioautographic study. Neuroendocrinology 56:25-31, 1992.
149. Liposits ZS, Merchenthaler I, Paull WK, Flerko B. Synaptic communication between somatostatinergic axons and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate nucleus of the rat. Histochemistry 89:247-252, 1988.
150. Willoughby JO, Brogan M, Kapoor R. Hypothalamic interconnections of somatostatin and growth hormone releasing factor neurons. Neuroendocrinology 50:584-591, 1989.
151. Tannenbaum GS, McCarthy GF, Zeitler P, Beaudet A. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: Morphological evidence for putative somatostatin/GRF interactions within hypothalamus. Endocrinology 127:2551-2560, 1990.
152. Minami S, Kamegai J, Sugihara H, Suzuki N, Wakabayashi I. Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus. Endoer J 45(Suppl):S19-S26, 1998.
153. Tannenbaum GS. Neuroendocrine control of growth hormone secretion. Acta Paediatr Suppl 372:5-16, 1991.
154. Robinson ICAF. Neuroendocrine control of GH secretion. Proc. 4th Intl. Cong. Neuroendocrinol. Folia Endocrinol Japon 74:401, 1998.
155. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132, 1993.
156. Houenou LJ, Oppenheim RW, Li L, Lo AC, Prevette D. Regulation of spinal motoneuron survival by GDNF during development and following injury. Cell Tissue Res 286:219-223, 1996.
157. Beck KI, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373:339-341, 1995.
158. Hoffer BJ, Hoffman A, Bowenkamp K, Huetti P, Hudson J, Martin D, Lin LF, Gerhardt GA. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neuroscience Lett 182:107-111, 1994.
159. Sauer H, Rosenblad C, Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor β-3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci U S A 92:8935-8939, 1995.
160. Cass WA. GDNF selectively protects dopamine neurons over serotonin neurons aaainst the neurotoxic effects of methamphetamine. J Neurosci 16:8132-8139, 1996.
161. Tomac A, Widenfalk J, Lin LF, Kohno T, Ebendal T, Hoffer BJ, Olson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A 92:8274-8278, 1995.
162. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins FA, Hoffer BJ, Gerhardt GA. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature 380:252-256, 1996.
163. Stromberg I, Bjorklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401-412, 1993.
164. Wang Y, Tien LT, Lapchak PA, Hoffer BJ. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Cell Tissue Res 286:225-233, 1996.
165. Sanchez MP, Silos-Santiago I, Friesen J, He B, Lira SA, Barbacid M. Renal asenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70-73, 1996.
166. Choi-Lundberg DL, Bohn MC. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in the rat. Brain Res Dev Brain Res 85:80-88, 1995.
167. Chang HT, Kuo H, Whittaker JA, Cooper NG. Light and electron microscopic analysis of projection neurons retrogradely labeled with Fluoro-Gold: Notes on the application of antibodies to Fluoro-Gold. J Neurosci Methods 35:31-37, 1990.
168. Romero MI, Phelps CJ. Identification of growth hormone-releasing hormone and somatostatin neurons projecting to the median eminence in normal and growth hormone-deficient Ames dwarf mice. Neuroendocrinology 65:107-116, 1997.
169. Gibson MJ, Krieger DT, Charlton HM, Zimmerman EA, Silverman AJ, Perlow MJ. Mating and pregnancy can occur in genetically hypogonadal mice with preoptic area brain grafts. Science 225:949-951, 1984.
170. Charlton HM, Wood MJ. Animal models for brain and pituitary gonadal disturbances. In: Swaab DF, Hofman MA, Mirmiran M, Ravid R, van Leeuwen FW, Eds. Progress in Brain Research. New York: Elsevier, Vol. 93: pp321-332, 1992.
171. Bruhn TO, Tresco PA, Jackson IM. Transplantation of fetal growth hormone-releasing factor-immunoreactive neurons into the ventricular system of adult MSG-treated rats. Peptides 12:957-961, 1991.
172. Saitoh Y, Gibson MJ, Silverman AJ. Targeting of gonadotropin-releasing hormone axons from preoptic area grafts to the median eminence. J Neurosci Res 33:379-391, 1992.
173. Wray S, Gähwiler BH, Gainer H. Slice cultures of LHRH neurons in the presence and absence of brainstem and pituitary. Peptides 9:1151-1175, 1988.
174. Tobet SA, Hanna IK, Schwarting GA. Migration of neurons containing gonadotropin releasing hormone (GnRH) in slices from embryonic nasal compartment and forebrain. Brain Res Dev Brain Res 97:287-292, 1996.
175. King JC, Rubin BS. Dynamic alterations in luteinizing hormone-releasing hormone (LHRH) neuronal cell bodies and terminals of adult rats. Cell Mol Neurobiol 15:89-106, 1995.
176. King JC, Rubin BS. Neuronal glial interactions and regulation of LHRH secretion (abstract). Proc Endocrine Soc Mtg S23-1, 1997.
177. Horseman ND, Yu-Lee L. Transcriptional regulation by the helix bundle peptide hormones: Growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev 15:627-649, 1994.
178. Darnell JE Jr. STATs and gene regulation. Science 277:1630-1635, 1997.
179. Moutoussamy S, Kelly PA, Finidori J. Growth-hormone-receptor and cytokine-receptor-family signaling. Eur J Biochem 255:1-11, 1998.
180. Carter-Su C, Smit LS. Signaling via JAK tyrosine kinases: Growth hormone receptor as a model system. Rec Prog Horm Res 53:61-82, 1998.
181. Yi W, Kim S-O, Jiang J, Park S-H, Kraft AS, Waxman DJ, Frank SJ. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Mol Endocrinol 10:1425-1443, 1996.
182. Gebert CA, Park S-H, Waxman DJ. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern growth hormone stimulation. Mol Endocrinol 11:400-414, 1998.
183. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95-97, 1996.
184. McCowen KC, Chow JC, Smith RJ. Leptin signaling in the hypothalamus of normal rats in vivo. Endocrinology 139:4442-4447, 1998.
185. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220, 1997.
186. Chandrashekar V, Bartke A, Coschigano KT, Kopchick JJ. Pituitary and testicular function in growth hormone receptor gene knockout mice. Endocrinology 140:1082-1088, 1999.
187. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11:167-178, 1997.
188. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakahima K, Engle SJ, Smith F, Markoff E, Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926-6935, 1997.
189. Steger RW, Chandrashekar V, Zhao W, Bartke A, Horseman ND. Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139:3691-3695, 1998.
190. Phelps CJ, Horseman ND. Hypophsiotropic dopamine neurons in PRL knockout mice (abstract). Proc Endocrine Soc Mtg P2-492, 1999.
191. Bartke A. Reproduction of female dwarf mice treated with prolactin. J Reprod Fertil 11:203-206, 1966.
192. Bartke A, Goldman BD, Bex F, Dalterio S. Effects of prolactin (PRL) on pituitary and testicular function in mice with hereditary PRL deficiency. Endocrinology 101:1760-1766, 1977.
193. Wennbo H, Kindblom J, Isaksson OG, Tornell J. Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138:4410-4415, 1997.
194. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707, 1996.
195. Pedrazzini T, Seydoux J, Künster P, Aubert J-F, Grouzmann E, Beermann F, Brunner H-R. Cardiovascular response, feeding behavior, and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4:722-726, 1998.
196. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4:718-721, 1998.